0
0
Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case–control study - The Lancet
10/25/23 at 10:37pm
Organization
The Lancet
Author
The Lancet
32 words
0
Comments
You are the first to view
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600%2823%2900306-5/fulltext
Create an account or login to join the discussion